Related Experiment Video
Updated: Jun 12, 2026
07:47
Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
Artificial Intelligence in Tumor Evolution: Understanding Cancer Complexity Through Multi-Modal Data Integration in
Asunción Espinosa-Sánchez1,2, Amancio Carnero1,2
1Instituto de Biomedicina de Sevilla (IBIS), HUVR/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain.
Cells
|June 11, 2026
Summary
Artificial intelligence (AI) is revolutionizing cancer research by decoding tumor complexity. AI models integrate multi-omics, imaging, and clinical data to understand tumor evolution, resistance, and metastasis for improved patient outcomes.
Area of Science:
- Oncology
- Bioinformatics
- Medical Imaging
Background:
- Cancer research is increasingly leveraging artificial intelligence (AI) to address challenges in understanding tumor biology.
- Tumor evolution, heterogeneity, resistance, and metastasis remain significant hurdles in oncology.
- Conventional methods struggle to capture the dynamic complexity of tumor processes.
Purpose of the Study:
- To explore the transformative role of AI in cancer research, particularly in decoding tumor complexity and evolution.
- To highlight AI's capability in integrating multi-modal data for a comprehensive understanding of cancer.
- To discuss the potential of AI in developing advanced therapeutic strategies and personalized medicine.
Main Methods:
- AI models are utilized for multi-modal data integration (multi-omics, imaging, clinical data).
- Deep learning techniques are applied in medical imaging for tumor segmentation and monitoring.
- AI tools are employed in functional genomics to predict genetic variant effects and map pathways.
Main Results:
- AI facilitates pattern recognition connecting molecular alterations with phenotypic outcomes.
- AI enhances tumor characterization, monitoring, and prediction of treatment response.
- AI aids in biomarker discovery, patient stratification, and clinical trial optimization.
Conclusions:
- AI offers powerful tools to decode tumor complexity, understand evolution, and overcome resistance.
- AI-driven insights can accelerate the development of adaptive and personalized cancer therapies.
- Responsible AI deployment in oncology requires addressing ethical considerations like data privacy and bias.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...